Private versus Social Incentives for Pharmaceutical Innovation
Author
Abstract
Suggested Citation
Download full text from publisher
Other versions of this item:
- González, Paula & Macho-Stadler, Inés & Pérez-Castrillo, David, 2016. "Private versus social incentives for pharmaceutical innovation," Journal of Health Economics, Elsevier, vol. 50(C), pages 286-297.
- Inés Macho-Stadler & David Pérez-Castrillo & Paula González, 2015. "Private versus Social Incentives for Pharmaceutical Innovation," Working Papers 860, Barcelona School of Economics.
- Paula González & Inés Macho-Stadler & David Pérez-Castrillo, 2015. "Private versus Social Incentives for Pharmaceutical Innovation," Working Papers 15.07, Universidad Pablo de Olavide, Department of Economics.
References listed on IDEAS
- Bardey, D. & Bommier, A. & Jullien, B., 2010.
"Retail price regulation and innovation: Reference pricing in the pharmaceutical industry,"
Journal of Health Economics, Elsevier, vol. 29(2), pages 303-316, March.
- Bardey, David & Bommier, Antoine & Jullien, Bruno, 2009. "Retail Price Regulation and Innovation: Reference Pricing in the Pharmaceutical Industry," IDEI Working Papers 432, Institut d'Économie Industrielle (IDEI), Toulouse.
- Bardey, David & Bommier, Antoine & Jullien, Bruno, 2009. "Retail Price Regulation and Innovation: Reference Pricing in the Pharmaceutical Industry," TSE Working Papers 09-026, Toulouse School of Economics (TSE).
- Ernst Berndt & Murray Aitken, 2011. "Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century after the 1984 Waxman-Hatch Legislation," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 18(2), pages 177-201.
- Juan-José Ganuza & Gerard Llobet & Beatriz Domínguez, 2009.
"R& D in the Pharmaceutical Industry: A World of Small Innovations,"
Management Science, INFORMS, vol. 55(4), pages 539-551, April.
- Beatriz Domínguez & Juan José Ganuza & Gerard Llobet, 2005. "R&D in the pharmaceutical industry: A world of small innovations," Economics Working Papers 936, Department of Economics and Business, Universitat Pompeu Fabra.
- Beatriz Domínguez & Juan-José Ganuza & Gerard Llobet, 2006. "R&D in the Pharmaceutical Industry: A World of Small Innovations," Working Papers wp2006_0601, CEMFI.
- Karan Girotra & Christian Terwiesch & Karl T. Ulrich, 2007. "Valuing R& D Projects in a Portfolio: Evidence from the Pharmaceutical Industry," Management Science, INFORMS, vol. 53(9), pages 1452-1466, September.
- Jasjit Singh & Lee Fleming, 2010. "Lone Inventors as Sources of Breakthroughs: Myth or Reality?," Management Science, INFORMS, vol. 56(1), pages 41-56, January.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2022.
"The price of cost-effectiveness thresholds,"
NIPE Working Papers
5/2022, NIPE - Universidade do Minho.
- Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2023. "The price of cost-effectiveness thresholds," Discussion Paper Series in Economics 4/2023, Norwegian School of Economics, Department of Economics.
- Bardey, David & Cremer, Helmuth & Lozachmeur, Jean-Marie, 2016.
"The design of insurance coverage for medical products under imperfect competition,"
Journal of Public Economics, Elsevier, vol. 137(C), pages 28-37.
- Bardey, David & Cremer, Helmuth & Lozachmeur, Jean-Marie, 2015. "The Design of Insurance Coverage for Medical Products under Imperfect Competition," IZA Discussion Papers 8815, Institute of Labor Economics (IZA).
- David Bardey & Helmuth Cremer & Jean-Marie Lozachmeur, 2015. "The Design of Insurance Coverage for Medical Products under Imperfect Competition," CESifo Working Paper Series 5235, CESifo.
- Bardey, David & Cremer, Helmuth & Lozachmeur, Jean-Marie, 2015. "The design of insurance coverage for medical products under imperfect competition," TSE Working Papers 15-553, Toulouse School of Economics (TSE).
- David Bardey & Helmuth Cremer & Jean-Marie Lozachmeur, 2015. "The design of insurance coverage for medical products under imperfect competition," Documentos CEDE 12564, Universidad de los Andes, Facultad de Economía, CEDE.
- Jullien, Bruno & Lefouili, Yassine, 2018.
"Horizontal Mergers and Innovation,"
CEPR Discussion Papers
12773, C.E.P.R. Discussion Papers.
- Bruno Jullien & Yassine Lefouili, 2018. "Horizontal mergers and innovation," Post-Print hal-03263838, HAL.
- Jullien, Bruno & Lefouili, Yassine, 2018. "Horizontal Mergers and Innovation," TSE Working Papers 18-892, Toulouse School of Economics (TSE), revised May 2018.
- Marie‐Louise Leroux & Gregory Ponthiere, 2020.
"Nursing home choice, family bargaining, and optimal policy in a Hotelling economy,"
Journal of Public Economic Theory, Association for Public Economic Theory, vol. 22(4), pages 899-932, August.
- Marie-Louise Leroux & Grégory Ponthiere, 2016. "Nursing Home Choice, Family Bargaining and Optimal Policy in a Hotelling Economy," CESifo Working Paper Series 5892, CESifo.
- Marie-Louise Leroux & Grégory Ponthiere, 2016. "Nursing Home Choice, Family Bargaining and Optimal Policy in a Hotelling Economy," Cahiers de recherche 1604, Chaire de recherche Industrielle Alliance sur les enjeux économiques des changements démographiques.
- Marie‐louise Leroux & Gregory Ponthiere, 2020. "Nursing home choice, family bargaining, and optimal policy in a Hotelling economy," PSE-Ecole d'économie de Paris (Postprint) halshs-03957863, HAL.
- LEROUX, Marie-Louise & PONTHIERE, Gregory, 2016. "Nursing Home Choice, Family Bargaining and Optimal Policy in a Hotelling Economy," LIDAM Discussion Papers CORE 2016018, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
- Marie‐louise Leroux & Gregory Ponthiere, 2020. "Nursing home choice, family bargaining, and optimal policy in a Hotelling economy," Post-Print halshs-03957863, HAL.
- Francesca Barigozzi & Izabela Jelovac, 2020.
"Research funding and price negotiation for new drugs,"
Health Economics, John Wiley & Sons, Ltd., vol. 29(S1), pages 83-96, October.
- Francesca Barigozzi & Izabela Jelovac, 2019. "Research funding and price negotiation for new drugs," Working Papers 1901, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
- Francesca Barigozzi & Izabela Jelovac, 2020. "Research funding and price negotiation for new drugs," Post-Print halshs-02910863, HAL.
- Francesca Barigozzi & Izabela Jelovac, 2019. "Research funding and price negotiation for new drugs," Post-Print halshs-02409768, HAL.
- Francesca Barigozzi & Izabela Jelovac, 2019. "Research funding and price negotiation for new drugs," Post-Print halshs-02148454, HAL.
- Francesca Barigozzi & Izabela Jelovac, 2019. "Research funding and price negotiation for new drugs," Working Papers halshs-01987643, HAL.
- Francesca Barigozzi & Izabela Jelovac, 2019. "Research funding and price negotiation for new drugs," Post-Print halshs-02148462, HAL.
- Francesca Barigozzi & Izabela Jelovac, 2019. "Research funding and price negotiation for new drugs," Post-Print halshs-02409743, HAL.
- Francesca Barigozzi & Izabela Jelovac, 2019. "Research funding and price negotiation for new drugs," Post-Print halshs-02409758, HAL.
- Patrick Leoni & Alvaro Sandroni, 2016. "Can patent duration hinder medical innovation," International Journal of Health Economics and Management, Springer, vol. 16(4), pages 397-406, December.
- Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2025. "Competition matters: uniform vs. indication-based pricing of pharmaceuticals," Discussion Paper Series in Economics 1/2025, Norwegian School of Economics, Department of Economics.
- Bingqiang Li & Lei Huang, 2019. "The Effect of Incremental Innovation and Disruptive Innovation on the Sustainable Development of Manufacturing in China," SAGE Open, , vol. 9(1), pages 21582440198, February.
- Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2024.
"Competing with precision: incentives for developing predictive biomarker tests,"
Scandinavian Journal of Economics, Wiley Blackwell, vol. 126(1), pages 60-97, January.
- Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2022. "Competing with precision: incentives for developing predictive biomarker tests," NIPE Working Papers 3/2022, NIPE - Universidade do Minho.
- Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2022. "Competing with precision: incentives for developing predictive biomarker tests," Discussion Paper Series in Economics 6/2022, Norwegian School of Economics, Department of Economics.
- Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2022.
"Paying for pharmaceuticals: uniform pricing versus two-part tariffs,"
Journal of Health Economics, Elsevier, vol. 83(C).
- Kurt R. Brekke & Dag Morten Dalen & Odd Rune Straume, 2021. "Paying for pharmaceuticals: uniform pricing versus two-part tariffs," NIPE Working Papers 01/2021, NIPE - Universidade do Minho.
- Kurt R. Brekke & Odd Rune Straume & Dag Morten Dalen, 2023.
"Taking the competitor´s pill: when combination therapies enter pharmaceutical markets,"
NIPE Working Papers
12/2023, NIPE - Universidade do Minho.
- Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2023. "Taking the competitor’s pill: when combination therapies enter pharmaceutical markets," Discussion Paper Series in Economics 19/2023, Norwegian School of Economics, Department of Economics.
- Jelena Grujić & Slobodan Morača & Angela Fajsi, 2020. "Analysis of Risk Factors in the Channels of Drug Distribution: Professional Perspectives," Sustainability, MDPI, vol. 12(11), pages 1-20, June.
- Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2023. "The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical markets," Journal of Health Economics, Elsevier, vol. 90(C).
- Le, Son & Sukhatme, Neel U., 2020. "Reaching for mediocrity: Competition and stagnation in pharmaceutical innovation," International Review of Law and Economics, Elsevier, vol. 64(C).
- Straume, Odd Rune, 2023. "Therapeutic reference pricing and drug innovation incentives," Economics Letters, Elsevier, vol. 222(C).
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Pankaj C. Patel & Marko Kohtamäki & Vinit Parida & Joakim Wincent, 2015. "Entrepreneurial orientation-as-experimentation and firm performance: The enabling role of absorptive capacity," Strategic Management Journal, Wiley Blackwell, vol. 36(11), pages 1739-1749, November.
- Baruch Lev & Suresh Radhakrishnan & Jamie Yixing Tong, 2021. "Earnings Component Volatilities: Capital Versus R&D Expenditures," Production and Operations Management, Production and Operations Management Society, vol. 30(5), pages 1475-1492, May.
- Puig-Junoy, Jaume & López-Valcárcel, Beatriz González, 2014. "Launch prices for new pharmaceuticals in the heavily regulated and subsidized Spanish market, 1995–2007," Health Policy, Elsevier, vol. 116(2), pages 170-181.
- Le, Son & Sukhatme, Neel U., 2020. "Reaching for mediocrity: Competition and stagnation in pharmaceutical innovation," International Review of Law and Economics, Elsevier, vol. 64(C).
- Keith M. Drake & Martha A. Starr & Thomas McGuire, 2014. "Do "Reverse Payment" Settlements of Brand-Generic Patent Disputes in the Pharmaceutical Industry Constitute an Anticompetitive Pay for Delay?," NBER Working Papers 20292, National Bureau of Economic Research, Inc.
- Rajat Khanna & Isin Guler, 2022. "Degree assortativity in collaboration networks and invention performance," Strategic Management Journal, Wiley Blackwell, vol. 43(7), pages 1402-1430, July.
- Keith M. Drake & Martha A. Starr & Thomas G. McGuire, 2015. "Do "Reverse Payment" Settlements Constitute an Anticompetitive Pay-for-Delay?," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 22(2), pages 173-200, July.
- Giuliani, Elisa & Martinelli, Arianna & Rabellotti, Roberta, 2016.
"Is Co-Invention Expediting Technological Catch Up? A Study of Collaboration between Emerging Country Firms and EU Inventors,"
World Development, Elsevier, vol. 77(C), pages 192-205.
- Giuliani , Elisa & Martinelli , Arianna & Rabellotti , Roberta, 2014. "Is Co-Invention Expediting Technological Catch Up? A Study of Collaboration between Emerging Country Firms and EU inventors," Papers in Innovation Studies 2014/25, Lund University, CIRCLE - Centre for Innovation Research.
- Elisa Giuliani & Arianna Martinelli & Roberta Rabellotti, 2015. "Is Co-Invention Expediting Technological Catch Up? A Study of Collaboration between Emerging Country Firms and EU inventors," LEM Papers Series 2015/10, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
- Boeker, Warren & Howard, Michael D. & Basu, Sandip & Sahaym, Arvin, 2021. "Interpersonal relationships, digital technologies, and innovation in entrepreneurial ventures," Journal of Business Research, Elsevier, vol. 125(C), pages 495-507.
- Sternitzke, Christian, 2013. "An exploratory analysis of patent fencing in pharmaceuticals: The case of PDE5 inhibitors," Research Policy, Elsevier, vol. 42(2), pages 542-551.
- Branstetter, Lee & Chatterjee, Chirantan & Higgins, Matthew J., 2022.
"Generic competition and the incentives for early-stage pharmaceutical innovation,"
Research Policy, Elsevier, vol. 51(10).
- Lee Branstetter & Chirantan Chatterjee & Matthew J. Higgins, 2014. "Generic Competition and the Incentives for Early-Stage Pharmaceutical Innovation," NBER Working Papers 20532, National Bureau of Economic Research, Inc.
- Thomas Ã…stebro & Kevyn Yong, 2016.
"Invention Quality and Entrepreneurial Earnings: The Role of Prior Employment Variety,"
Entrepreneurship Theory and Practice, , vol. 40(2), pages 381-400, March.
- Astebro, Thomas B & Yong, Kevyn, 2015. "Invention Quality and Entrepreneurial Earnings: The Role of Prior Employment Variety," HEC Research Papers Series 1129, HEC Paris.
- Thomas Astebro & Kevyn Yong, 2016. "Invention Quality and Entrepreneurial Earnings: The Role of Prior Employment Variety," Working Papers hal-01993434, HAL.
- Krzysztof Klincewicz & Szymon Szumiał, 2022. "Successful patenting—not only how, but with whom: the importance of patent attorneys," Scientometrics, Springer;Akadémiai Kiadó, vol. 127(9), pages 5111-5137, September.
- Lara Agostini & Federico Caviggioli & Francesco Galati & Barbara Bigliardi, 2020. "A social perspective of knowledge-based innovation: mobility and agglomeration. Introduction to the special section," The Journal of Technology Transfer, Springer, vol. 45(5), pages 1309-1323, October.
- Aschhoff, Birgit & Sofka, Wolfgang, 2008.
"Successful Patterns of Scientific Knowledge Sourcing: Mix and Match,"
ZEW Discussion Papers
08-033 [rev.], ZEW - Leibniz Centre for European Economic Research.
- Sofka, Wolfgang & Aschhoff, Birgit, 2008. "Successful Patterns of Scientific Knowledge Sourcing: Mix and Match," ZEW Discussion Papers 08-033, ZEW - Leibniz Centre for European Economic Research.
- Madjid Tavana & Mariya Sodenkamp & Leena Suhl, 2010. "A soft multi-criteria decision analysis model with application to the European Union enlargement," Annals of Operations Research, Springer, vol. 181(1), pages 393-421, December.
- Mirko Kremer & Francis de Véricourt, 2022. "Mismanaging diagnostic accuracy under congestion," ESMT Research Working Papers ESMT-22-01, ESMT European School of Management and Technology.
- Glenn Dutcher & Cortney S. Rodet, 2022.
"Which two heads are better than one? Uncovering the positive effects of diversity in creative teams,"
Journal of Economics & Management Strategy, Wiley Blackwell, vol. 31(4), pages 884-897, November.
- Dutcher, E. Glenn & Rodet, Cortney S., 2018. "Which Two Heads are Better than One? Uncovering the Positive Effects of Diversity in Creative Teams," MPRA Paper 89982, University Library of Munich, Germany.
- Carolin Haeussler & Henry Sauermann, 2016. "The Division of Labor in Teams: A Conceptual Framework and Application to Collaborations in Science," NBER Working Papers 22241, National Bureau of Economic Research, Inc.
- Niccolò Innocenti & Francesco Capone & Luciana Lazzeretti & Sergio Petralia, 2022. "The role of inventors’ networks and variety for breakthrough inventions," Papers in Regional Science, Wiley Blackwell, vol. 101(1), pages 37-57, February.
More about this item
Keywords
pharmaceuticals; R&D activities; me-too drugs; breakthrough drugs; incremental innovation; radical innovation;All these keywords.
JEL classification:
- I10 - Health, Education, and Welfare - - Health - - - General
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ces:ceswps:_5672. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Klaus Wohlrabe (email available below). General contact details of provider: https://edirc.repec.org/data/cesifde.html .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.